Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China
· Delayed Price · Currency is CNY 4.900
+0.100 (2.08%)
At close: Mar 10, 2026
SHE:002793 Revenue
Luoxin Pharmaceuticals Group Stock had revenue of 594.52M CNY in the quarter ending June 30, 2025, with 4.21% growth. This brings the company's revenue in the last twelve months to 2.49B, up 2.96% year-over-year. In the year 2024, Luoxin Pharmaceuticals Group Stock had annual revenue of 2.65B with 11.99% growth.
Revenue (ttm)
2.49B
Revenue Growth
+2.96%
P/S Ratio
2.09
Revenue / Employee
779.06K
Employees
3,196
Market Cap
5.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | 283.50M | 11.99% |
| Dec 31, 2023 | 2.36B | -1.22B | -34.11% |
| Jan 1, 2023 | 3.59B | -2.89B | -44.62% |
| Jan 1, 2022 | 6.48B | 381.70M | 6.26% |
| Dec 31, 2020 | 6.10B | -1.49B | -19.67% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hubei Biocause Heilen Pharmaceutical | 430.77M |
| Nanjing Hicin Pharmaceutical | 615.39M |
| Fuan Pharmaceutical (Group) | 1.71B |
| Zhejiang Yatai Pharmaceutical | 326.64M |
| Beijing Science Sun Pharmaceutical | 402.23M |
| Bide Pharmatech | 1.32B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Jianmin Pharmaceutical Group | 3.18B |